_id
69105e5bccc777a4e85d5917
Ticker
DWTX
Name
Dogwood Therapeutics, Inc.
Exchange
NASDAQ
Address
44 Milton Avenue, Alpharetta, GA, United States, 30009
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://dwtx.com
Description
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a fixed dose combination of famciclovir and celecoxib that has completed Phase 2b clinical trial to treat fibromyalgia; Halneuron, which is in Phase 2b clinical trial for the treatment of chemotherapy-induced neuropathic pain and cancer pain, as well as pre-clinical trial for burn and ocular pain; and IMC-2, a combination of valacyclovir and celecoxib in Phase 2 clinical trial for the treatment of long-COVID and post-acute sequelae of COVID-19 infection. The company was formerly known as Virios Therapeutics, Inc. and changed its name to Dogwood Therapeutics, Inc. in October 2024. The company was incorporated in 2012 and is based in Alpharetta, Georgia.
Last Close
4.09
Volume
11353
Current Price
4.17
Change
0.02
Last Updated
2026-01-02T12:57:14.396Z
Image
data:image/webp;base64,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
Ipo Date
2020-12-17T00:00:00.000Z
Market Cap
123667920
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-0.9595
Sentiment Sources
2
Rating
4
Target Price
19
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
15809125
Operating Income
-15809125
Interest Expense
-
Pretax Income
-15746052
Net Income
-15744616
Eps
-8.202743205936336
Dividends Per Share
-
Shares Outstanding
29727866
Income Tax Expense
-1436
EBITDA
-15728796
Operating Margin
-
Total Other Income Expense Net
63073
Cash
10126710
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
11655377
Property Plant Equipment
189301
Total Assets
91992613
Payables
584602
Short Term Debt
54566
Long Term Debt
-
Total Liabilities
14607504
Equity
77385109
Bs_currency_symbol
USD
Depreciation
17338
Change In Working Capital
361733
Cash From Operations
-3272792
Capital Expenditures
2
Cash From Investing
-
Cash From Financing
0
Net Change In Cash
-3276099
Cf_currency_symbol
USD
PE
-
PB
0.10343121194027136
ROE
-20.345795468221155
ROA
-17.11508727336618
FCF
-3272794
Fcf Percent
-
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
5.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
5.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
15809125
Quarters > 0 > income Statement > operating Income
-15809125
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-15746052
Quarters > 0 > income Statement > net Income
-15744616
Quarters > 0 > income Statement > eps
-8.202743205936336
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1919433
Quarters > 0 > income Statement > income Tax Expense
-1436
Quarters > 0 > income Statement > EBITDA
-15728796
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
63073
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
10126710
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
11655377
Quarters > 0 > balance Sheet > property Plant Equipment
189301
Quarters > 0 > balance Sheet > total Assets
91992613
Quarters > 0 > balance Sheet > payables
584602
Quarters > 0 > balance Sheet > short Term Debt
54566
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
14607504
Quarters > 0 > balance Sheet > equity
77385109
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-15744616
Quarters > 0 > cash Flow > depreciation
17338
Quarters > 0 > cash Flow > change In Working Capital
361733
Quarters > 0 > cash Flow > cash From Operations
-3272792
Quarters > 0 > cash Flow > capital Expenditures
2
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-3276099
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-8.202743205936336
Quarters > 0 > ratios > PB
0.10343121194027136
Quarters > 0 > ratios > ROE
-20.345795468221155
Quarters > 0 > ratios > ROA
-17.11508727336618
Quarters > 0 > ratios > FCF
-3272794
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
17256
Quarters > 1 > income Statement > gross Profit
-17256
Quarters > 1 > income Statement > operating Expenses
3923115
Quarters > 1 > income Statement > operating Income
-3923115
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-3807204
Quarters > 1 > income Statement > net Income
-3807353
Quarters > 1 > income Statement > eps
-2.641179714679144
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1441535
Quarters > 1 > income Statement > income Tax Expense
149
Quarters > 1 > income Statement > EBITDA
-3905859
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
115911
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
13402809
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
14704294
Quarters > 1 > balance Sheet > property Plant Equipment
207143
Quarters > 1 > balance Sheet > total Assets
96692527
Quarters > 1 > balance Sheet > payables
498118
Quarters > 1 > balance Sheet > short Term Debt
54496
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
14151904
Quarters > 1 > balance Sheet > equity
82540623
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-3807353
Quarters > 1 > cash Flow > depreciation
17256
Quarters > 1 > cash Flow > change In Working Capital
-296023
Quarters > 1 > cash Flow > cash From Operations
-4026118
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-120133
Quarters > 1 > cash Flow > net Change In Cash
-4136195
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-2.641179714679144
Quarters > 1 > ratios > PB
0.07282718171390588
Quarters > 1 > ratios > ROE
-4.612702038849404
Quarters > 1 > ratios > ROA
-3.9375876483195023
Quarters > 1 > ratios > FCF
-4026118
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
17022
Quarters > 2 > income Statement > gross Profit
-17022
Quarters > 2 > income Statement > operating Expenses
4429926
Quarters > 2 > income Statement > operating Income
-4429926
Quarters > 2 > income Statement > interest Expense
147090
Quarters > 2 > income Statement > pretax Income
-10734410
Quarters > 2 > income Statement > net Income
-10924952
Quarters > 2 > income Statement > eps
-7.578693545422068
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1441535
Quarters > 2 > income Statement > income Tax Expense
190542
Quarters > 2 > income Statement > EBITDA
-4412904
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-6304484
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
17539004
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
19163772
Quarters > 2 > balance Sheet > property Plant Equipment
209658
Quarters > 2 > balance Sheet > total Assets
96984688
Quarters > 2 > balance Sheet > payables
1153642
Quarters > 2 > balance Sheet > short Term Debt
50719
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
89897757
Quarters > 2 > balance Sheet > equity
7086931
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-10924952
Quarters > 2 > cash Flow > depreciation
17022
Quarters > 2 > cash Flow > change In Working Capital
-243019
Quarters > 2 > cash Flow > cash From Operations
-4682554
Quarters > 2 > cash Flow > capital Expenditures
4
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
7372378
Quarters > 2 > cash Flow > net Change In Cash
2691055
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-7.578693545422068
Quarters > 2 > ratios > PB
0.8482093236127175
Quarters > 2 > ratios > ROE
-154.15631956907723
Quarters > 2 > ratios > ROA
-11.264615296798192
Quarters > 2 > ratios > FCF
-4682558
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
24
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
12177
Quarters > 3 > income Statement > gross Profit
-12177
Quarters > 3 > income Statement > operating Expenses
7542151
Quarters > 3 > income Statement > operating Income
-7542151
Quarters > 3 > income Statement > interest Expense
155437
Quarters > 3 > income Statement > pretax Income
-7728375
Quarters > 3 > income Statement > net Income
-7727872
Quarters > 3 > income Statement > eps
-5.897005205749981
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1310474
Quarters > 3 > income Statement > income Tax Expense
-503
Quarters > 3 > income Statement > EBITDA
-7572938
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-186224
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
14847949
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
16544462
Quarters > 3 > balance Sheet > property Plant Equipment
222648
Quarters > 3 > balance Sheet > total Assets
94308246
Quarters > 3 > balance Sheet > payables
1231805
Quarters > 3 > balance Sheet > short Term Debt
99392
Quarters > 3 > balance Sheet > long Term Debt
15381077
Quarters > 3 > balance Sheet > total Liabilities
30027223
Quarters > 3 > balance Sheet > equity
64281023
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-7727872
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-2161604
Quarters > 3 > cash Flow > cash From Operations
-6131508
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
3761936
Quarters > 3 > cash Flow > cash From Financing
15322294
Quarters > 3 > cash Flow > net Change In Cash
12808130
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-5.897005205749981
Quarters > 3 > ratios > PB
0.08501228395198378
Quarters > 3 > ratios > ROE
-12.022011535192899
Quarters > 3 > ratios > ROA
-8.194269671816397
Quarters > 3 > ratios > FCF
-6131508
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
42
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
12177
Annuals > 0 > income Statement > gross Profit
-12177
Annuals > 0 > income Statement > operating Expenses
12227248
Annuals > 0 > income Statement > operating Income
-12227248
Annuals > 0 > income Statement > interest Expense
92192
Annuals > 0 > income Statement > pretax Income
-12350227
Annuals > 0 > income Statement > net Income
-12349724
Annuals > 0 > income Statement > eps
-12.015839857869384
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1027787
Annuals > 0 > income Statement > income Tax Expense
-503
Annuals > 0 > income Statement > EBITDA
-12245858
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-122979
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
14847949
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
16544462
Annuals > 0 > balance Sheet > property Plant Equipment
222648
Annuals > 0 > balance Sheet > total Assets
94308246
Annuals > 0 > balance Sheet > payables
1231805
Annuals > 0 > balance Sheet > short Term Debt
99392
Annuals > 0 > balance Sheet > long Term Debt
15381077
Annuals > 0 > balance Sheet > total Liabilities
30027223
Annuals > 0 > balance Sheet > equity
64281023
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-12349724
Annuals > 0 > cash Flow > depreciation
12177
Annuals > 0 > cash Flow > change In Working Capital
-581268
Annuals > 0 > cash Flow > cash From Operations
-8790805
Annuals > 0 > cash Flow > capital Expenditures
5
Annuals > 0 > cash Flow > cash From Investing
3761936
Annuals > 0 > cash Flow > cash From Financing
16704464
Annuals > 0 > cash Flow > net Change In Cash
11531003
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-12.015839857869384
Annuals > 0 > ratios > PB
0.06651409265841958
Annuals > 0 > ratios > ROE
-19.21208379026575
Annuals > 0 > ratios > ROA
-13.09506275835095
Annuals > 0 > ratios > FCF
-8790810
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
5446919
Annuals > 1 > income Statement > operating Income
-5446919
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-5296015
Annuals > 1 > income Statement > net Income
-5296015
Annuals > 1 > income Statement > eps
-7.051284099639049
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
751071
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-5446919
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
150904
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
3316946
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
4165442
Annuals > 1 > balance Sheet > property Plant Equipment
0
Annuals > 1 > balance Sheet > total Assets
4165442
Annuals > 1 > balance Sheet > payables
111913
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
358548
Annuals > 1 > balance Sheet > equity
3806894
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-5296015
Annuals > 1 > cash Flow > depreciation
0
Annuals > 1 > cash Flow > change In Working Capital
-194446
Annuals > 1 > cash Flow > cash From Operations
-4870489
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
1156443
Annuals > 1 > cash Flow > net Change In Cash
-3714046
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-7.051284099639049
Annuals > 1 > ratios > PB
0.8207361066528251
Annuals > 1 > ratios > ROE
-139.11642929905588
Annuals > 1 > ratios > ROA
-127.14172949713381
Annuals > 1 > ratios > FCF
-4870489
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
12315309
Annuals > 2 > income Statement > operating Income
-12315309
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-12247834
Annuals > 2 > income Statement > net Income
-12247834
Annuals > 2 > income Statement > eps
-27.659718521061237
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
442804
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-12315309
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
67475
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
7030992
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
8369756
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
8369756
Annuals > 2 > balance Sheet > payables
573164
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1043262
Annuals > 2 > balance Sheet > equity
7326494
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-12247834
Annuals > 2 > cash Flow > depreciation
-
Annuals > 2 > cash Flow > change In Working Capital
197378
Annuals > 2 > cash Flow > cash From Operations
-11467797
Annuals > 2 > cash Flow > capital Expenditures
3
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
4490605
Annuals > 2 > cash Flow > net Change In Cash
-6977192
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-27.659718521061237
Annuals > 2 > ratios > PB
0.251425120937791
Annuals > 2 > ratios > ROE
-167.17182870824706
Annuals > 2 > ratios > ROA
-146.3344212184919
Annuals > 2 > ratios > FCF
-11467800
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
15640940
Annuals > 3 > income Statement > operating Income
-15640940
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-15960268
Annuals > 3 > income Statement > net Income
-15960268
Annuals > 3 > income Statement > eps
-47.903989530932975
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
333172
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-15640940
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-319328
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
14008184
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
15776687
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
15776687
Annuals > 3 > balance Sheet > payables
353863
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1275623
Annuals > 3 > balance Sheet > equity
14501064
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-15960268
Annuals > 3 > cash Flow > depreciation
-
Annuals > 3 > cash Flow > change In Working Capital
-52191
Annuals > 3 > cash Flow > cash From Operations
-15689578
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
-97604
Annuals > 3 > cash Flow > net Change In Cash
-15787182
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-47.903989530932975
Annuals > 3 > ratios > PB
0.09557888441841234
Annuals > 3 > ratios > ROE
-110.06273746533357
Annuals > 3 > ratios > ROA
-101.16362199490932
Annuals > 3 > ratios > FCF
-15689578
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-8.202743205936336
Valuation > metrics > PB
0.10343121194027136
Valuation > final Score
70
Valuation > verdict
89.7% Undervalued
Profitability > metrics > ROE
-20.345795468221155
Profitability > metrics > ROA
-135.08457083799178
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.18876375815403967
Risk > metrics > Interest Coverage
-916.1523528048215
Risk > final Score
-3605
Risk > verdict
High
Liquidity > metrics > Current Ratio
18.235232364573946
Liquidity > metrics > Quick Ratio
18.235232364573946
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-99
Prev Risks > 1
-114
Prev Risks > 2
-134
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:44:35.388Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-07
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-8.2
Earnings History > 0 > eps Estimate
-0.05
Earnings History > 0 > eps Difference
-8.15
Earnings History > 0 > surprise Percent
-16300
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-13
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-9.51
Earnings History > 1 > eps Estimate
-0.05
Earnings History > 1 > eps Difference
-9.46
Earnings History > 1 > surprise Percent
-18920
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-07
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-8.4504
Earnings History > 2 > eps Estimate
-0.765
Earnings History > 2 > eps Difference
-7.6854
Earnings History > 2 > surprise Percent
-1004.6275
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-13
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-6.29
Earnings History > 3 > eps Estimate
-0.0567
Earnings History > 3 > eps Difference
-6.2333
Earnings History > 3 > surprise Percent
-10993.4744
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-11
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-2.05
Earnings History > 4 > eps Estimate
-0.06
Earnings History > 4 > eps Difference
-1.99
Earnings History > 4 > surprise Percent
-3316.6667
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.05
Earnings History > 5 > eps Estimate
-0.0633
Earnings History > 5 > eps Difference
0.0133
Earnings History > 5 > surprise Percent
21.0111
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.07
Earnings History > 6 > eps Estimate
-0.05
Earnings History > 6 > eps Difference
-0.02
Earnings History > 6 > surprise Percent
-40
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-29
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.06
Earnings History > 7 > eps Estimate
-0.06
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
0
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-13
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.06
Earnings History > 8 > eps Estimate
-0.09
Earnings History > 8 > eps Difference
0.03
Earnings History > 8 > surprise Percent
33.3333
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.08
Earnings History > 9 > eps Estimate
-0.05
Earnings History > 9 > eps Difference
-0.03
Earnings History > 9 > surprise Percent
-60
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.08
Earnings History > 10 > eps Estimate
-0.16
Earnings History > 10 > eps Difference
0.08
Earnings History > 10 > surprise Percent
50
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-14
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.11
Earnings History > 11 > eps Estimate
-0.15
Earnings History > 11 > eps Difference
0.04
Earnings History > 11 > surprise Percent
26.6667
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.28
Earnings History > 12 > eps Estimate
-0.46
Earnings History > 12 > eps Difference
0.18
Earnings History > 12 > surprise Percent
39.1304
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.44
Earnings History > 13 > eps Estimate
-0.44
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
0
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-12
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.48
Earnings History > 14 > eps Estimate
-0.48
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
0
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-17
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.54
Earnings History > 15 > eps Estimate
-0.54
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
0
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-11
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.49
Earnings History > 16 > eps Estimate
-0.7
Earnings History > 16 > eps Difference
0.21
Earnings History > 16 > surprise Percent
30
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-12
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.51
Earnings History > 17 > eps Estimate
-0.56
Earnings History > 17 > eps Difference
0.05
Earnings History > 17 > surprise Percent
8.9286
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-13
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-9.1762
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-03
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-19.57
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a fixed dose combination of famciclovir and celecoxib that has completed Phase 2b clinical trial to treat fibromyalgia; Halneuron, which is in Phase 2b clinical trial for the treatment of chemotherapy-induced neuropathic pain and cancer pain, as well as pre-clinical trial for burn and ocular pain; and IMC-2, a combination of valacyclovir and celecoxib in Phase 2 clinical trial for the treatment of long-COVID and post-acute sequelae of COVID-19 infection. The company was formerly known as Virios Therapeutics, Inc. and changed its name to Dogwood Therapeutics, Inc. in October 2024. The company was incorporated in 2012 and is based in Alpharetta, Georgia.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ADogwood Therapeutics Raises Capital via Registered Direct Financing The Globe and Mail
Read more →Dogwood Therapeutics, Inc. Announces Financing of up to $26.8 Million to Progress Halneuron® Through Phase 2b Development Sahm
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$19
Analyst Picks
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bearish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Dogwood Therapeutics, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-8.2
EPS Estimate
-0.05
EPS Difference
-8.15
Surprise Percent
-16300%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.